Stock ECOR ELECTROCORE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases electroCore, Inc.

Equities

ECOR

US28531P2020

Delayed Nasdaq
Other stock markets
 15:18:37 2024-06-21 EDT 		5-day change 1st Jan Change
5.91 USD -3.27% Intraday chart for electroCore, Inc. -4.06% -0.70%
06-05 ElectroCore, Inc. announced that it has received $2.817568 million in funding CI
05-31 ElectroCore, Inc. announced that it expects to receive $2.817568 million in funding CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
ElectroCore to Join Russell Microcap® Index
AQ
ElectroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
AQ
ElectroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
AQ
ElectroCore Announces First Quarter 2024 Financial Results
AQ
ElectroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
AQ
ElectroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024
AQ
Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion
AQ
ElectroCore Announces the Launch of Truvaga Plus® for General Wellness
AQ
ElectroCore Expands Intellectual Property Portfolio
AQ
ElectroCore Announces Fourth Quarter and Full Year 2023 Financial Results
AQ
ElectroCore to Participate in Upcoming Investor Conferences
AQ
ElectroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
AQ
ElectroCore Expands Intellectual Property Portfolio
AQ
ElectroCore Expands Intellectual Property Portfolio
AQ
ElectroCore Expands Intellectual Property Portfolio
AQ
ElectroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology
AQ
Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023
AQ
ElectroCore Announces Third Quarter 2023 Financial Results
AQ
ElectroCore to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
AQ
Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ECOR Stock
  4. News electroCore, Inc.
  5. Press Releases